M&A Deal Summary

Boston Scientific Acquires Obsidio

On August 15, 2022, Boston Scientific acquired medical products company Obsidio

Acquisition Highlights
  • This is Boston Scientific’s 45th transaction in the Medical Products sector.
  • This is Boston Scientific’s 45th transaction in the United States.
  • This is Boston Scientific’s 1st transaction in South Carolina.

M&A Deal Summary

Date 2022-08-15
Target Obsidio
Sector Medical Products
Buyer(s) Boston Scientific
Deal Type Add-on Acquisition

Target

Obsidio

Columbia, South Carolina, United States
website
Obsidio is a privately-held company that has developed the Gel Embolic Material technology used for embolization of blood vessels in the peripheral vasculature. Obsidio is based in Columbia, South Carolina.

Search 191,421 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States

website


Category Company
Founded 1979
Sector Medical Products
Employees45,000
Revenue 12.7B USD (2022)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.


DEAL STATS #
Overall 59 of 62
Sector (Medical Products) 45 of 48
Type (Add-on Acquisition) 46 of 48
State (South Carolina) 1 of 1
Country (United States) 45 of 47
Year (2022) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-15 M.I.Tech

Pyeongtaek-si, South Korea

M.I.Tech develops, manufactures, and provides its own unique medical devices in the field of digestive endoscopy to improve patients’ quality of life. It manufactures all products under a strict quality management system by maintaining the global standard, ISO 13485:2003. M.I.Tech was formed in 1991 and is based in Pyeongtaek-si, South Korea.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-11 Acotec

Beijing, China

Acotec is a medical technology company that offers solutions designed for a variety of interventional procedures in innovative medical solutions, including drug-coated balloons (DCBs), which are used in the treatment of vascular and other diseases. In 2016, the company launched the first peripheral DCB in China after receiving approval from the National Medical Products Administration. The Acotec portfolio also includes radiofrequency ablation technologies and thrombus aspiration catheters, as well as more than 20 other products in various stages of development across a range of specialties. Acotec is based in Beijing, China.

Buy -